Technical Analysis for ARVN - Arvinas, Inc.

Grade Last Price % Change Price Change
D 63.0 0.17% 0.11
ARVN closed up 0.17 percent on Thursday, April 15, 2021, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Apr 26
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ARVN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
20 DMA Resistance Bearish 0.17%
Multiple of Ten Bullish Other 2.71%
Multiple of Ten Bullish Other 4.22%
Wide Bands Range Expansion -0.77%
Older End-of-Day Signals for ARVN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 14 hours ago
Down 1% about 14 hours ago
20 DMA Resistance about 17 hours ago
10 DMA Resistance about 17 hours ago
Rose Above 20 DMA about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Genetics Proprietary Technology Metabolism Androgen Receptor Chimera

Is ARVN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 92.77
52 Week Low 19.68
Average Volume 410,827
200-Day Moving Average 46.99
50-Day Moving Average 71.71
20-Day Moving Average 63.60
10-Day Moving Average 63.71
Average True Range 4.13
ADX 23.15
+DI 18.10
-DI 21.89
Chandelier Exit (Long, 3 ATRs ) 66.88
Chandelier Exit (Short, 3 ATRs ) 68.98
Upper Bollinger Band 68.43
Lower Bollinger Band 58.77
Percent B (%b) 0.44
BandWidth 15.19
MACD Line -2.46
MACD Signal Line -2.72
MACD Histogram 0.2692
Fundamentals Value
Market Cap 2.55 Billion
Num Shares 40.5 Million
EPS -7.16
Price-to-Earnings (P/E) Ratio -8.80
Price-to-Sales 39.19
Price-to-Book 4.98
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 66.70
Resistance 3 (R3) 66.85 65.76 66.08
Resistance 2 (R2) 65.76 64.82 65.69 65.88
Resistance 1 (R1) 64.38 64.24 63.84 64.23 65.67
Pivot Point 63.30 63.30 63.03 63.22 63.30
Support 1 (S1) 61.92 62.36 61.38 61.77 60.33
Support 2 (S2) 60.83 61.77 60.76 60.12
Support 3 (S3) 59.45 60.83 59.92
Support 4 (S4) 59.30